Brief: ALX Oncology Q4 Basic EPS USD -0.42
27/02/2026 13:00
Feb 27 (Reuters) - ALX Oncology Q4 operating expenses USD 23.021 million. Q4 net income USD -22.848 million Q4 income from operations USD -23.021 million Q4 EPS USD -0.42
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing